Camana Bay, Cayman Islands

David Lickrish

USPTO Granted Patents = 23 

 

Average Co-Inventor Count = 2.0

ph-index = 10

Forward Citations = 189(Granted Patents)


Location History:

  • Grand Cayman, KY (2015 - 2019)
  • Camana Bay, KY (2014 - 2024)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: David Lickrish: A Pioneer in ADHD Therapeutic Compositions

Introduction:

David Lickrish, a resident of Camana Bay in the Cayman Islands, is a renowned inventor and researcher in the field of attention deficit hyperactivity disorder (ADHD) treatments. With an impressive portfolio of 21 patents, Lickrish has made significant contributions to the development of delayed and extended release formulations for therapeutic compositions. He is currently affiliated with Ironshore Pharmaceuticals & Development, Inc., an esteemed pharmaceutical company specializing in ADHD treatments. Let's delve into Lickrish's latest patents, career highlights, and collaborations.

Latest Patents:

Lickrish's recent patents highlight his commitment to advancing the treatment of ADHD. His innovative compositions focus on delivering therapeutic amounts of methylphenidate in delayed and extended release formulations. The dosage forms developed by Lickrish exhibit a lag time of 6 to 8 hours or longer, ensuring controlled delivery of the medication followed by a sustained release period. These breakthrough formulations offer considerable advantages in managing ADHD symptoms effectively.

Career Highlights:

Lickrish's career is marked by his dedication to innovation and scientific excellence. His profound understanding of ADHD therapeutics led him to join Ironshore Pharmaceuticals & Development, Inc. as a key researcher. Through his meticulous research, Lickrish has successfully filed and obtained 21 patents, solidifying himself as a prominent figure in the field.

Collaborations:

Lickrish has also had the opportunity to collaborate with fellow experts in the field, working alongside Feng Zhang, a renowned scientist. Their joint efforts have significantly contributed to the research and development of advanced therapeutic compositions for ADHD treatment. Such collaborations foster an environment of innovation and knowledge sharing, leading to revolutionary advancements in the field.

Conclusion:

David Lickrish's accomplishments as an inventor and researcher in the field of ADHD treatment have been nothing short of remarkable. Through his patented formulations, he has revolutionized the way ADHD is managed, offering delayed and extended release therapeutic compositions that provide enhanced efficacy and convenience. Lickrish's collaborations and his association with Ironshore Pharmaceuticals & Development, Inc. underline his commitment to addressing the needs of individuals affected by ADHD. As he continues his journey of innovation, we eagerly anticipate further breakthroughs from this visionary inventor.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…